Junko Murai
Keio University
H-index: 34
Asia-Japan
Top articles of Junko Murai
Schlafen 11 further sensitizes BRCA-deficient cells to PARP inhibitors through single-strand DNA gap accumulation behind replication forks
2024/2/2
Junko Murai
H-Index: 27
Yusuke Kobayashi
H-Index: 12
SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian …
Molecular cancer therapeutics
2024/1/3
Junko Murai
H-Index: 27
Kosuke Yoshihara
H-Index: 27
Epigenetic upregulation of Schlafen11 renders WNT-and SHH-activated medulloblastomas sensitive to cisplatin
Neuro-oncology
2023/5/1
Junko Murai
H-Index: 27
Tetsuya Yamamoto
H-Index: 16
BRCAness, homologous recombination deficiencies, and synthetic lethality
Cancer Research
2023/4/14
Junko Murai
H-Index: 27
Schlafen family member 11 indicates favorable prognosis of patients with head and neck cancer following platinum-based chemoradiotherapy
Frontiers in oncology
2023/1/19
The germline factor DDX4 contributes to the chemoresistance of small cell lung cancer cells
Communications Biology
2023/1/18
Synergistic effects of PARP inhibitors by Schlafen 11 and BRCA2-deficiency through accumulation of single-strand DNA gaps behind a fork
bioRxiv
2023
Junko Murai
H-Index: 27
Metabolic clogging of mannose triggers dNTP loss and genomic instability in human cancer cells
Elife
2023/7/18
Junko Murai
H-Index: 27
The crucial role of single-stranded DNA binding in enhancing sensitivity to DNA-damaging agents for Schlafen 11 and Schlafen 13
Iscience
2023/12/15
10199-SPDR-2 PERSONALIZED SYNTHETIC LETHALITY INDUCED BY TARGETING ATR-CHK1 IN MEDULLOBLASTOMAS IDENTIFIED BY IMPLEMENTATION OF SLFN11 IMMUNOHISTOCHEMISTRY
Neuro-Oncology Advances
2023/12/1
Junko Murai
H-Index: 27
Schlafen 11 (SLFN11) kills cancer cells undergoing unscheduled re-replication
Molecular cancer therapeutics
2023/8/1
Junko Murai
H-Index: 27
263 SLFN11 is a possible biomarker of sensitivity to DNA-targeted regents in CD30-positive mycosis fungoides and Sezary syndrome
Journal of Investigative Dermatology
2023/5/1
SPDR-4 SLFN11 RENDERS MEDULLOBLASTOMA SENSITIVE TO DNA DAMAGE CHEMOTHERAPIES
Neuro-Oncology Advances
2022/12
Junko Murai
H-Index: 27
Metabolic clogging of mannose triggers genomic instability via dNTP loss in human cancer cells
bioRxiv
2022/10/17
Junko Murai
H-Index: 27
Successful Treatment of Acute Uric Acid Nephropathy with Rasburicase in a Primary Central Nervous System Lymphoma Patient Showing a Dramatic Response to Methotrexate—Case Report
Journal of Clinical Medicine
2022/9/22
Junko Murai
H-Index: 27
Hiroshi Shimizu
H-Index: 29
Reconsidering the mechanisms of action of PARP inhibitors based on clinical outcomes
2022/9
Junko Murai
H-Index: 27
Prognostic impact of Schlafen 11 in bladder cancer patients treated with platinum‐based chemotherapy
Cancer Science
2022/2
Schlafen 11, a crucial determinant of sensitivity to DNA damaging agents~ basic and clinic~
Fujita Medical Journal
2022
Junko Murai
H-Index: 27
Schlafen 11 expression in human acute leukemia cells with gain-of-function mutations in the interferon-JAK signaling pathway
Iscience
2021/10/22
Junko Murai
H-Index: 27
Schlafen 11 predicts response to platinum-based chemotherapy in gastric cancers
British Journal of Cancer
2021/7/6
